Spina Bifida: NICHD Research Goals

Myelomeningocele is the most common severely disabling birth defect in North America. The NICHD integrates extensive intramural and extramural programs to advance treatment for spina bifida, provides effective support and rehabilitation, and investigates possible avenues for prevention. The NICHD’s research portfolio includes:

  • Genetic determinants of spina bifida
  • Prenatal diagnosis and repair
  • Defining developmental effects of spina bifida
  • Assessing interventions to support robust motor development, learning capacity, and social integration
top of pageBACK TO TOP